Vivani Medical (VANI) awards 80,000 options and 40,000 RSUs to CMO

Rhea-AI Filing Summary

Vivani Medical, Inc. reported equity awards to Chief Medical Officer Lisa Ellen Porter on July 28, 2026. She received stock options for 80,000 shares at a $1.31 exercise price, vesting 25% after one year and monthly over 36 months within a 10-year term, plus 40,000 performance-based RSUs that vest in three stages if the share price reaches $3.15 for three consecutive trading days within four years.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Porter Lisa Ellen

Role Chief Medical Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Stock Option F1	80,000	$0.00	$0.00
Grant/Award	RSUs F2, F3	40,000	$0.00	$0.00

Holdings After Transaction: Common Stock Option — 80,000 shares (Direct); RSUs — 40,000 shares (Direct)

Footnotes (3)

1. F1. The stock options have a 10-year term and vest 25% at one-year and monthly thereafter for 36 months, subject to the Reporting Person's continued service through each applicable vesting date.
2. F2. Each restricted stock unit ("RSU") represents a contingent right to receive one share of Vivani common stock.
3. F3. The performance based RSUs shall vest in three stages: one-third when the stock price is at or above $3.15 for three consecutive trading days, another one-third one year after this date when the market condition is first achieved, and the final one-third one year after this second vesting date when the market condition is achieved, subject to the Reporting Person's continued service through each applicable vesting date. If the RSUs fail to be at or above $3.15 for three consecutive trading dates within a four year term from the date of the grant, the RSUs shall expire.

Key Figures

Stock options granted: 80,000 shares Option exercise price: $1.31 per share Option term: 10 years +3 more

6 metrics

Stock options granted 80,000 shares Common Stock Options granted to CMO on July 28, 2026

Option exercise price $1.31 per share Conversion or exercise price of Common Stock Options

Option term 10 years Stock options have a 10-year term from grant

RSUs granted 40,000 units Performance-based RSUs granted, each RSU equals one share of common stock

RSU price hurdle $3.15 per share Stock price must be at or above $3.15 for three consecutive trading days

RSU performance term 4 years RSUs expire if the $3.15 condition is not met within four years from grant

Key Terms

Common Stock Option, restricted stock unit ("RSU"), performance based RSUs, market condition

4 terms

Common Stock Option financial

"The stock options have a 10-year term and vest 25% at one-year"

restricted stock unit ("RSU") financial

"Each restricted stock unit ("RSU") represents a contingent right to receive"

performance based RSUs financial

"The performance based RSUs shall vest in three stages: one-third"

market condition financial

"another one-third one year after this date when the market condition is first achieved"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/30/2026 - 08:27 PM Accepted by SEC EDGAR 07/30/2026 - 08:26 PM Learn about SEC filing dates

FAQ

What equity awards did Vivani Medical (VANI) grant to CMO Lisa Ellen Porter?

Lisa Ellen Porter received 80,000 stock options with a $1.31 exercise price and 40,000 performance-based RSUs, each RSU representing one share of Vivani Medical common stock, subject to specified vesting and performance conditions.

What are the vesting terms of the 80,000 Vivani Medical (VANI) stock options?

The 80,000 stock options have a 10-year term and vest 25% after one year, then monthly over the next 36 months, contingent on Lisa Ellen Porter’s continued service through each applicable vesting date.

How do the performance-based RSUs for Vivani Medical (VANI) vest?

The 40,000 performance-based RSUs vest in three equal stages. One-third vests when the stock trades at or above $3.15 for three consecutive days, then additional one-third tranches vest one year after each prior vest, subject to continued service.

What happens if Vivani Medical (VANI) stock never reaches the $3.15 condition for the RSUs?

If the share price does not reach $3.15 for three consecutive trading days within four years from the grant date, the performance-based RSUs expire and no shares are delivered under those RSUs.

Does Lisa Ellen Porter’s Vivani Medical (VANI) Form 4 report any stock sales?

The reported transactions show only awards of options and RSUs to Lisa Ellen Porter. There are no sales or dispositions of Vivani Medical securities reported in this Form 4; both entries are coded as acquisitions.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Porter Lisa Ellen

(Last) (First) (Middle)

C/O VIVANI MEDICAL, INC.

1350 S. LOOP ROAD

(Street)

ALAMEDA CALIFORNIA 94502

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Vivani Medical, Inc. [ VANI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Medical Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/28/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Common Stock Option	$1.31	07/28/2026		A		80,000		(1)	07/27/2036(1)	Common Stock	80,000	$0	80,000	D
RSUs	(2)	07/28/2026		A		40,000		(3)	(3)	Common Stock	40,000	$0	40,000	D

Explanation of Responses:

1. The stock options have a 10-year term and vest 25% at one-year and monthly thereafter for 36 months, subject to the Reporting Person's continued service through each applicable vesting date.

2. Each restricted stock unit ("RSU") represents a contingent right to receive one share of Vivani common stock.

3. The performance based RSUs shall vest in three stages: one-third when the stock price is at or above $3.15 for three consecutive trading days, another one-third one year after this date when the market condition is first achieved, and the final one-third one year after this second vesting date when the market condition is achieved, subject to the Reporting Person's continued service through each applicable vesting date. If the RSUs fail to be at or above $3.15 for three consecutive trading dates within a four year term from the date of the grant, the RSUs shall expire.

Remarks:

Exhibit 24.1 Power of Attorney

	/s/ Adam Mendelsohn, Attorney-in-fact	07/30/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)